Rey Ximenes, MD
Interventional Pain Medicine · Marble Falls, TXNPI 1801816228
Payments from drug & device makers
Across 33 payments — averaging $41.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$278
- AbbVie$152
- Inspire Medical Systems, Inc.$146
- Biodelivery Sciences International, Inc.$124
- Teleflex LLC$111
- Collegium Pharmaceutical, Inc.$105
- plus $440 from 11 others
What the payments were for
- Food & beverage$1,356100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 5 | $278 |
| AbbVie | 5 | $152 |
| Inspire Medical Systems, Inc. | 1 | $146 |
| Biodelivery Sciences International, Inc. | 1 | $124 |
| Teleflex LLC | 1 | $111 |
| Collegium Pharmaceutical, Inc. | 5 | $105 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $78 |
| Stimwave Technologies Incorporated | 1 | $70 |
| Pfizer | 4 | $66 |
| SPR Therapeutics, Inc | 1 | $48 |
| Vertex | 1 | $37 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $37 |
| Braeburn Inc. | 1 | $29 |
| Averitas Pharma Inc. | 1 | $27 |
| GRT US Holding, Inc. | 1 | $21 |
| IBSA Pharma Inc. | 1 | $16 |
| Spinesmith Holdings, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$149
- Inspire$146
- BELBUCA$124
- Barrigel$111
How this compares
$1,356 in reported general payments places this provider in the 20th percentile of 287 interventional pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 294 | $42,143 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 581 | $20,654 |
| OxycontinOxycodone Hcl | 31 | $14,081 |
| Morphine Sulfate ErMorphine Sulfate | 197 | $6,342 |
| Fentanyl | 62 | $5,496 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 156 | $4,203 |
| Buprenorphine Hcl | 127 | $3,760 |
| Oxycodone Hcl | 208 | $3,295 |
| Methadone Hcl | 130 | $2,730 |
| Gabapentin | 145 | $1,918 |
| Tramadol Hcl ErTramadol Hcl | 18 | $1,296 |
| Pregabalin | 68 | $1,166 |
| Tizanidine Hcl | 94 | $1,160 |
| Methocarbamol | 57 | $969 |
| Hydromorphone Hcl | 50 | $781 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Marble Falls
- Gabor RaczLubbock$3M
- Pankaj MehtaKilleen$2.2M
- Genaro GutierrezAustin$1.3M
- Chad StephensSouthlake$1.1M
- Ioannis SkaribasHouston$979K
- Duane GriffithTyler$730K
- Brannon FrankAustin$698K
- Robert WillsRound Rock$692K
- Ankur KhoslaShenandoah$511K
- Brian RichDecatur$245K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.